FindTrial
Sign In

Diagnosis of colorectal cancer by serum and exosomal CEA family and detection of circulating tumo cells

Diagnosis of colorectal cancer by serum and exosomal CEA family and detection of circulating tumo cells - Diagnosis of colorectal cancer by CEA family and circulating tumo cells

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013680
Enrollment
1000
Registered
2014-04-14
Start date
2014-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Sponsors

Wakayama Medical University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Colorectal cancer patients with informed consent agreement

Exclusion criteria

Exclusion criteria: Colorectal cancer patients without informed consent agreement

Design outcomes

Primary

MeasureTime frame
Prediction of malignant phenotype of colorectal cancer by serum and exosomal CEA family and detection of circulating tumor cells.—

Countries

Japan

Contacts

Public ContactShozo Yokoyama

Wakayama Medical University, School of Medicine Second Department of Surgery

yokoyama@wakayama-med.ac.jp073-441-0613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026